THYNC - Key Persons
Prior to joining Thync as Chief Software Technology Officer, Anil was Senior VP and Officer of R&D and Support at Accelrys. It was there that he led the company's technology architecture and software development strategy and played an integral role in M&A strategy and integration. Previously, Anil spent 12 years at Oracle serving as a Vice President in their Server Technology organization, Vice President of Service Engineering and Senior Director of Oracle Cloud Services. Anil has also established and led global teams at Auspex Systems and VeriFone.
Job Titles:
- Director of Specialized Performance Programs, LA Dodgers
- Director of Specialized Performance, LA Dodgers
After receiving his PhD in Clinical Psychology at California School of Professional Psychology, Dr. Potterat has worked as a high performance psychologist for the US Navy SEALS, the Memphis Grizzlies, the USA Women's National Soccer Team, Red Bull, and currently works with the Los Angeles Dodgers, where he helped the organization win their first World Series in 32 years.
Dr. Jamie Tyler's scientific and engineering efforts focus on developing products and solutions for noninvasive medical and consumer health devices, as well as neuromodulation solutions for national defense and security needs. These include methods and devices for cognitive and physical performance enhancement, as well as for treatment of mental health conditions, and he is credited with discovering Thync's core technology.
Prior to Thync, Dr. Tyler was an Associate Professor in the School of Biological and Health Systems Engineering at Arizona State University. He is an expert in neurobiology, bioimaging and investigating brain circuit plasticity and function, and has deep experience in developing, applying, and advancing brain stimulation and neuromodulation technologies. Previously, Jamie was an Assistant Professor of Biomedical Engineering and Sciences, as well as Psychiatry and Behavioral Medicine, at the Virginia Tech Carilion School of Medicine and Research Institute.
Job Titles:
- Head of Clinical Sciences, Noctrix Health
Dr. Charlesworth received his PhD in Neuroscience from University of California - San Francisco. He was an early member of the Thync team, where he developed several different neurostimulation waveforms and products to improve mood, sleep, and focus. He has over 15 patents in neurostimulation and has been first-author on several publications in Nature and Nature Neuroscience.
In 2013, Dr. Pal created the first embodiment of the method used in the Thync bioelectronics platform for noninvasive modulation of autonomic neural circuits. Dr. Pal then led the development and testing of Thync's neuromodulation platform and was the architect of the algorithms used for stress and anxiety reduction. In 2017, Dr. Pal discovered the link between the use of Thync's neuromodulation platform and autoimmune disorders. Tragically in 2019, Dr. Pal passed away unexpectedly - we celebrate his legacy and our hearts are with his family.
Prior to Thync, Dr. Pal was at the Molecular and Cellular Biology Department and Center for Brain Science at Harvard University where he researched extensively on brain circuit plasticity and function, carbon nanotube arrays for detecting electrical activity in brain tissue, and cortical circuitry involved in sensory information processing. Dr. Pal received a PhD. in Neurobiology from the University of Pittsburgh School of Medicine where he discovered a novel cellular pathway involved in neurodegeneration which has since led to therapies being developed for stroke recovery.
Prior to Thync, Dr. Law was program manager at Apple Inc. as part of the iPod and iPhone leadership teams for the development of 5 generations of iPods and 4 generations of iPhones. Before working on smart devices and wearables, Dr. Wing Law spent approx. 10 years in the development of medical systems and devices. Dr. Law has over 15 patents assigned to him, and in his career developed over 30 commercially successful and ground breaking devices and systems in consumer electronics and healthcare.
Isy Goldwasser co-founded Thync to advance a new frontier within the healthcare and consumer product industries. Prior to founding Thync, Mr. Goldwasser was the first employee and a founding member of Symyx Technologies, Inc. (Nasdaq: SMMX) where he served numerous roles including President and then CEO over a period of 16 years - including taking the company public and building the publicly traded business for 10 years.
Mr. Goldwasser established a number of large, strategic partnerships with global corporations that totaled more than $500M in revenue. After constructing a successful merger between Symyx and Accelrys (Nasdaq: ACCL), Mr. Goldwasser became an Entrepreneur-in-Residence at Khosla Ventures in 2010. He is a named inventor on more than 40 U.S., European and Canadian patents and currently serves on the Board of Directors for The Scripps Research Institute.
Job Titles:
- Chief Strategy Officer, Noosphere Ventures
- Private Investor and Global Executive
Ms. Seredyuk is a private investor and global executive at a number of large-scale companies in adtech, martech, and consumer marketing. She leads diverse, distributed global teams to achieve new, ambitious objectives and deliver breakthrough business performance. An expert in go-to-market strategy, Ms. Seredyuk has successfully orchestrated rapid growth for Thync.